Method Characteristic | Reference Measurement Procedure | Designated Comparison Method |
---|---|---|
General & Pre-analytical | ||
Intended use | Higher order RMP as an essential part of the apo(a) traceability chain and future RMS | Designated Comparison Method for the future apolipoprotein RMS |
Measurands addressed and units of reporting | Serum apo(a) (nmol/L) | Serum apo(a) (nmol/L) |
Sample matrix | Serum | Serum |
Automation | No, Manual | Yes, Semi-automated |
Transition selection | Three transitions per peptide | Three transitions per peptide |
Liquids applied in sample preparation | Buffer: 100 mM Ammonium Bicarbonate, pH 8.1 Reduction mix: 1.15 mmol/L TCEP, 0.40% (v/v) DOC | Buffer: 100 mM tris(hydroxymethyl)aminomethane, pH op 8.1 Reduction mix: 0.5 mM TCEP, 0.523% (v/v) DOC |
Pre-digestion | LysC, 1:700 w/w LysC-to-protein ratio | None |
Pre-digestion time | 1 h, 37 °C | N.A |
Digestion | Trypsin, 1:47 w/w Trypsin-to-protein ratio | Trypsin, 1:35 w/w trypsin-to-protein ratio |
Digestion time | 3 h, 37 °C | 3 h, 37 °C |
Main technology of sample purification | Solid phase extraction (off-line) with Oasis HLB 3 mg/well, eluted using 0.2 mL 80% MeOH | Solid phase extraction (off-line) with Oasis HLB 3 mg/well, eluted using 0.1 mL 55% MeOH |
Proteotypic peptides of apo(a) | ||
Apo(a) | LFLEPTQADIALLK GISSTTVTGR TPENYPNAGLTR | LFLEPTQADIALLK GISSTTVTGR |
LC–MS acquisition conditions | ||
General LC setup | Agilent 1290 infinity II ultra-high performance LC system | Agilent 1290 infinity II ultra-high performance LC system |
Guard column | Zorbax SB-C18 | Zorbax SB-C18 |
Guard column geometry | 2.1 × 5 mm, 1,8 µm | 2.1 × 5 mm, 1,8 µm |
Analytical column | Zorbax SB-C18 | Zorbax SB-C18 |
Main column geometry | 2.1 × 50 mm, 1,8 µm | 2.1 × 50 mm, 1,8 µm |
Mobile phase constituents | MeOH (HPLC grade), FA, Ultrapure water | MeOH (HPLC grade), FA, Ultrapure water |
Flow Rate | 0.2 mL/min | 0.2 mL/min |
Sample injection Volume | 10 μL | 10 μL |
Ionization Mode | Positive | Positive |
total running window | 20 min | 19 min |
Mass spectrometer | Agilent 6495A triple quadrupole mass spectrometer | Agilent 6495A & 6495C triple quadrupole mass spectrometer |
Gradient, generic description | A: 5% MeOH and 0.05% FA in water; B: 95% MeOH and 0.05% FA in water. Starting condition: A 92% - Linear decrease to 82% A over 7 min—Linear decrease to 40% A at 15 min—Washing step: Steep decrease to 5% A at 15.1 min—Isocratic hold at 5% A until 17 min—Reequilibration: 3 min using starting conditions | A: 5% MeOH and 0.05% FA in water; B: 95% MeOH and 0.05% FA in water. Starting condition: A 95% - Linear decrease to 67% A over 8 min—Linear decrease to 43% A at 12 min—Washing step: Steep decrease to 5% A at 12.1 min—Isocratic hold at 5% A until 16 min—Reequilibration: 3 min using starting conditions |
Main MS ionization mode | Electrospray, positive polarity | Electrospray, positive polarity |
Fragmentation | Collision induced dissociation | Collision induced dissociation |
Run acceptance & quantitation | ||
Internal Standard | In house (13C, 15N)R or (13C,15N)K SIL peptides | In house (13C, 15N)R or (13C,15N)K SIL peptides |
Calibration concentrations | MCA 2013.2062 apo(a): 93.4 nmol/L; | MCA 2019.1564/2019.1565/2019.1566/2019.1568/2019.15611 apo(a): 17.1 – 41.2 – 93.4 – 270.7 – 9.9 nmol/L; |
Type of calibration and calibration samples matrix | External protein calibration based on a native human serum sample with internal standard | External protein calibration based on native human serum samples with internal standard |
Traceability | Indirect traceability to secondary reference material for apo(a): SRM-2B | Indirect traceability to secondary reference material for apo(a): SRM-2B |
Data Analysis Software | Mass Hunter Workstation Quantitative/Qualitative Analysis software/Skyline | Mass Hunter Workstation Quantitative/Qualitative Analysis software |
Interpretation of data | All transitions (both quantifying and qualifying) were evaluated individually | All transitions (both quantifying and qualifying) were evaluated individually |